SMYD2 and urinary bladder cancer: Methylation of p53, the most commonly mutated gene in invasive bladder cancer has been extensively studied and has been found to be methylated by SET7/9, SMYD2, SETD8, and G9a/GLP at K372, K370, K382, and K373, respectively [37].